The Antifungal Eugenol Perturbs Dual Aromatic and Branched-Chain Amino Acid Permeases in the Cytoplasmic Membrane of Yeast

PLoS ONE

Volumn 8, Issue 10, 2013, Pages

  Darvishi, Emad ^a,b   Omidi, Mansoor ^a   Bushehri, Ali Akbar Shahnejat ^a   Golshani, Ashkan ^b   Smith, Myron L ^b  

^a UNIVERSITY OF TEHRAN   (Iran)

^b CARLETON UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GALACTOSIDASE; EUGENOL;

AMINO ACID TRANSPORT; ANTIFUNGAL ACTIVITY; ARTICLE; BAP2 GENE; BIOASSAY; BIOSYNTHESIS; CELL CYCLE REGULATION; CELL MEMBRANE; CONTROLLED STUDY; DRUG STRUCTURE; ENZYME ACTIVITY; FUNGAL GENE; FUNGAL STRAIN; GAP1 GENE; GENE DELETION; GENE OVEREXPRESSION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; SACCHAROMYCES CEREVISIAE; TAT1 GENE; TAT2 GENE;

AMINO ACID TRANSPORT SYSTEMS; AMINO ACIDS, AROMATIC; AMINO ACIDS, BRANCHED-CHAIN; ANTIFUNGAL AGENTS; CELL MEMBRANE; EUGENOL; GENE DELETION; METABOLIC NETWORKS AND PATHWAYS; PHENOTYPE; PROTEIN BIOSYNTHESIS; SACCHAROMYCES CEREVISIAE; YEASTS;

EID: 84885746970     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0076028     Document Type: Article

References (44)

1. Hagan P, Projan S, Rosamond J, (2002) Infectious diseases: back to the future? Trends in Microbiology 10: sl-s2.
2. Loeffler J, Stevens DA, (2003) Antifungal drug resistance. Clinical Infectious Diseases 36: S31-S41.
3. Eloff JN, (1998) Which extractant should be used for the screening and isolation of antimicrobial components from plants? Journal of Ethnopharmacology 60: 1-8.
4. Schmid R, (1972) A resolution of the Eugenia-Syzygium controversy (Myrtaceae). American Journal of Botany 59: 423-436.
5. Boulos L (1983) In Medicinal plants of North Africa, Reference publications, Algonac, Michigan 48001, 286 p.
6. Chaieb K, Hajlaoui H, Zmantar T, Kahla-Nakbi AB, Mahmoud R, et al. (2007) The chemical composition and biological activity of clove essential oil, Eugenia caryophyllata (Syzigium aromaticum L. Myrtaceae): a short review. Phytotherapy Research 21: 501-506.
7. Gayoso CW, Lima EO, Oliveira VT, Pereira FO, Souza EL, et al. (2005) Sensitivity of fungi isolated from onychomycosis to Eugenia cariophyllata essential oil and eugenol. Fitoterapia 76: 247-249.
8. Lopez P, Sanchez C, Batlle R, Neri{dotless}n C, (2005) Solid- and vapour-phase antimicrobial activities of six essential oils: susceptibility of selected food borne bacterial and fungal strains. Journal of Agricultural and Food Chemistry 53: 6939-6946.
9. Jirovetz L, Buchbauer G, Stoilova I, Stoyanova A, Krastanov A, et al. (2006) Chemical composition and antioxidant properties of clove leaf essential oil. Journal of Agricultural and Food Chemistry 54: 6303-6307.
10. Pinto E, Vale-Silva L, Carlos C, Salgueiro L, (2009) Antifungal activity of the clove essential oil from Syzygium aromaticum on Candida, Aspergillus and dermatophyte species. Journal of Medical Microbiology 58: 1454-1462.
11. Carrasco H, Raimindi M, Svetaz L, Liberto MD, Rodriguez MV, et al. (2012) Antifungal activity of eugenol analogues. Influence of different substituents and studies on mechanism of action. Molecules 17: 1002-1024.
12. Zore GB, Thakre AD, Jadhav S, Karuppayil SM, (2011) Terpenoids inhibit Candida albicans growth by affecting membrane integrity and arrest of cell cycle. Phytomedicine 18: 1181-1190.
13. Roberts SK, McAinsh M, Widdicks L, (2012) Cch1p mediates Ca2+ influx to protect Saccharomyces cerevisiae against eugenol toxicity. PLoS One 7: e43989.
14. Sherman F, Fink GR, Lawrence CW (1986) Methods in Yeast Genetics: A Laboratory Manual. Cold Spring Harbor Laboratory press, New York, NY.
15. Mir-Rashed N, Cruz I, Jessulat M, Dumontier M, Chesnais C, et al. (2010) Disruption of fungal cell wall by antifungal Echinacea extracts. Medical Mycology 48: 949-58.
16. CLSI (2008) Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts. Approved standard M27- A3, 3rded, Clinical and Laboratory Standards Institute, Wayne, PA.
17. Tong AH, Evangelista M, Parsons AB, Xu H, Bader GD, et al. (2001) Systematic genetic analysis with ordered arrays of yeast deletion mutants. Science 294: 2364-2368.
18. Galván IJ, Mir-Rashed N, Jessulat M, Atanya M, Golshani A, et al. (2008) Antifungal and antioxidant activities of the phytomedicine pipsissewa, Chimaphila umbellata. Phytochemistry 69: 738-746.
19. Memarian N, Jessulat M, Alirezaie J, Mir-Rashed N, Xu J, et al. (2007) Colony size measurement of the yeast gene deletion strains for functional genomics. BMC Bioinformatics 8: 117.
20. Hong EL, Balakrishnan R, Christie KR, Costanzo MC, Dwight SS, et al. (2006) Saccharomyces Genome Database. http://www.yeastgenome.org/(accessed August 2012).
21. Trombetta D, Castelli F, Sarpietro MG, Venuti V, Cristani M, et al. (2005) Mechanisms of antibacterial action of three monoterpenes. Antimicrobial Agents and Chemotherapy 49: 2474.
22. Alamgir M, Eroukova V, Jessulat M, Xu J, Golshani A, (2008) Chemical-genetic profile analysis in yeast suggests that a previously uncharacterized open reading frame, YBR261C, affects protein synthesis. BMC Genomics 9: 583.
23. Miller J (1972) Experiments in Molecular Genetics, Cold Spring Harbor Laboratory, New York. 352-355.
24. Sopko R, Huang D, Preston N, Chua G, Papp B, et al. (2006) Mapping pathways and phenotypes by systematic gene overexpression. Molecular Cell 21: 319-330.
25. Alamgir M, Erukova V, Jessulat M, Azizi A, Golshani A, (2010) Chemical-genetic profile analysis of five inhibitory compounds in yeast. BMC Chemical Biology 10: 6.
26. Gietz RD, Woods RA, (2002) Transformation of yeast by lithium acetate/single-stranded carrier DNA/polyethylene glycol method. Methods in Enzymology 350: 87-96.
27. Schreve JL, Garrett JM, (2004) Yeast Agp2p and Agp3p function as amino acid permeases in poor nutrient conditions. Biochemical and Biophysical Research Communication 313: 745-751.
28. Regenberg B, Düring-Olsen L, Kielland-Brandt MC, Holmberg S, (1999) Substrate specificity and gene expression of the amino-acid permeases in Saccharomyces cerevisiae. Current Genetics 36: 317-328.
29. Gao M, Kaiser CA, (2006) A conserved GTPase-containing complex is required for intracellular sorting of the general amino-acid permease in yeast. Nature Cell Biology 8: 657-667.
30. Tarassov K, Messier V, Landry CR, Radinovic S, Serna Molina MM, et al. (2008) An in vivo map of the yeast protein interactome. Science 320: 1465-1470.
31. Costanzo M, Baryshnikova A, Bellay J, Kim Y, Spear ED, et al. (2009) Combinatorial effects of environmental parameters on transcriptional regulation in Saccharomyces cerevisiae: a quantitative analysis of a compendium of chemostat-based transcriptome data. BMC Genomics 10: 53.
32. Urrestarazu A, Vissers S, Iraqui I, Grenson M, (1998) Phenylalanine- and tyrosine-auxotrophic mutants of Saccharomyces cerevisiae impaired in transamination. Molecular Genetics and Genomics 257: 230-237.
33. Kispal G, Steiner H, Court DA, Rolinski B, Lill R, (1996) Mitochondrial and cytosolic branched-chain amino acid transaminases from yeast, homologs of the myc oncogene-regulated Eca39 protein. Journal of Biological Chemistry 271: 24458-24464.
34. Grauslund M, Didion T, Kielland-Brandt MC, Andersen HA, (1995) BAP2, a gene encoding a permease for branched-chain amino acids in Saccharomyces cerevisiae. Biochimica et Biophysica Acta 1269: 275-280.
35. Schmidt A, Hall MN, Koller A, (1994) Two FK506 resistance conferring genes in Saccharomyces cerevisiae, TAT1 and TAT2, encode amino-acid permeases mediating tyrosine and tryptophan uptake. Molecular and Cellular Biology 14: 6597-6606.
36. Louie GV, Baiga TJ, Bowman ME, Koeduka T, Taylor JH, et al. (2007) Structure and reaction mechanism of basil eugenol synthase. PLoS ONE 2: e993.
37. Lauwers E, Grossmann G, André B, (2007) Evidence for coupled biogenesis of yeast Gap1 permease and sphingolipids: essential role in transport activity and normal control by ubiquitination. Molecular Biology of the Cell 18: 3068-3080.
38. Donaton MCV, Holsbeeks I, Lagatie O, Zeebroeck GV, Crauwels M, et al. (2003) The Gap1 general amino acid permease acts as an amino acid sensor for activation of protein kinase A targets in the yeast Saccharomyces cerevisiae. Molecular Microbiology 50: 911-929.
39. Hughes TR, (2002) Yeast and drug discovery. Functional and integrative genomics 2: 199-211.
40. Dixon SJ, Stockwell BR, (2009) Identifying druggable disease-modifying gene products. Current Opinion in Chemical Biology 13: 549-555.
41. Fu YM, Yu ZX, Playo BA, Ferrans VJ, Meadows GG, (1999) Focal adhesion kinase-dependent apoptosis of melanoma induced by tyrosine and phenylalanine deficiency. Cancer Research 59: 758-765.
42. Tsukahara K, Watanabe T, Hata-sugi N, Yoshimatsu K, Okayama H, et al. (2001) Anticancer agent E7070 inhibits amino acid and uracil transport in fission yeast. Molecular Pharmacology 6: 1254-1259.
43. Nawashiro H, Otani N, Shinomiya N, Fukui S, Ooigawa H, et al. (2006) L-type amino acid transporter 1 as a potential molecular target in human astrocytic tumors. International Journal of Cancer 119: 484-492.
44. Esponel-Ingroff A, (2008) Mechanisms of resistance to antifungal agents: Yeasts and filamentous fungi. Revista Iberoamericana Micologia 25: 101-106.